Informations sur le produit
Nom :
Revatropate
Synonymes :
- (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate
- (R)-3-Quinuclidinyl (S)-beta-hydroxy-alpha-(2-(R)-methylsulfinyl)ethyl)hydratropate
- Uk-112,166
- Unii-3W7L15V40W
- Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-
- (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate
Description :
Revatropate is a chiral compound that belongs to the class of antimuscarinic drugs. It is used to treat motility disorders such as constipation, diarrhea, and irritable bowel syndrome. Revatropate has been shown to have high activity against syncytial virus infections and inflammatory bowel disease. This drug also inhibits the synthesis of phospholipase A 2 , which has been implicated in the pathogenesis of autoimmune diseases. The molecular mechanism for this effect is not known, but it may be due to the inhibition of water vapor loss from the bladder by reducing ileal motility.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
365.49 g/mol
Formule :
C19H27NO4S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
